(PharmaNewsWire.Com, April 20, 2017 ) According to Publisher, the Global Blood Flow Measurement Devices market is accounted for $335.7 million in 2016 and is expected to reach $608.2 million by 2022 growing at a CAGR of 10.4% from 2016 to 2022. Growing demand for blood flow measurement devices in healthcare industry would be the major factor fostering the blood flow measurement devices market. Furthermore, rising prevalence of cardiovascular disease and diabetes coupled with increasing geriatric population, rising demand for minimally invasive surgeries, technological advancements in blood flow measurement devices, wide usage of these devices in various clinical applications, influx of VC funding, huge R&D investments by market players and increasing demand for technically advanced non-invasive devices are the factors fuelling market growth. However, stringent compliance requirements, high pricing of the devices, growing alternative methods to treat cardiovascular diseases and implementation of the Patient Protection and Affordable Healthcare Act, 2010 are limiting the market growth.
Ultrasonic doppler segment is projected to witness substantial breakthrough advancements over the coming decade and is expected to provide lucrative avenues of growth. In Non-invasive applications, cardiovascular disease segment accounted for the major share whereas, Coronary Artery Bypass Grafting (CABG) devices dominated the invasive applications segment. North American region dominated the global blood flow measurement devices market with maximum revenue share due to rising prevalence of cardiovascular diseases & hypertension, increasing geriatric population, continues R&D activities for advanced products and favourable reimbursement scenario. Asia Pacific is expected to witness fastest growth on account of rapidly increasing demand for advanced healthcare technologies, increasing prevalence of cardiovascular diseases and diabetes in countries such as India and China. Some of the key players in global market include Ace Medicals, Adinstruments, ATYS Medical, Biomedix Inc, Biopac Systems Inc., Compumedics Limited, Cook Medical, Inc., Deltex Medical Group PLC, Getinge Group, Medistim ASA, Medtronics, Moor Instruments Ltd., Perimed AB, Sonotec Ultraschallsensorik Halle GmbH and Transonic Systems, Inc.
Regions Covered: -North America -US -Canada -Mexico -Europe -Germany -France -Italy -UK -Spain -Rest of Europe -Asia Pacific -Japan -China -India -Australia -New Zealand -Rest of Asia Pacific - Rest of the World -Middle East -Brazil -Argentina -South Africa -Egypt
Company Profiling 10.1 Ace Medicals 10.2 Adinstruments 10.3 ATYS Medical 10.4 Biomedix Inc 10.5 Biopac Systems Inc. 10.6 Compumedics Limited 10.7 Cook Medical, Inc. 10.8 Deltex Medical Group PLC 10.9 Getinge Group 10.10 Medistim ASA 10.11 Medtronics 10.12 Moor Instruments Ltd. 10.13 Perimed AB 10.14 Sonotec Ultraschallsensorik Halle GmbH 10.15 Transonic Systems, Inc.
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Biotechnology & Pharmaceuticals resource center today to browse our selection of 600+ complimentary Biotechnology & Pharmaceuticals magazines, white papers, webinars, podcasts, and more. Get popular titles including:
